Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Cytosorbents (CTSO) Other Gross PP&E Adjustments (2016 - 2026)

Cytosorbents filings provide 15 years of Other Gross PP&E Adjustments readings, the most recent being $1.2 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 25.95% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 25.95% increase, with the full-year FY2025 number at $1.2 million, up 25.95% from a year prior.
  • Other Gross PP&E Adjustments hit $1.2 million in Q4 2025 for Cytosorbents, down from $1.7 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $1.9 million in Q2 2025 to a low of -$13.7 million in Q3 2021.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$11.7 million (2024), compared with a mean of -$6.8 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 1328.29% in 2022 and later surged 1125.08% in 2024.
  • Cytosorbents' Other Gross PP&E Adjustments stood at -$3.8 million in 2021, then skyrocketed by 84.67% to -$586530.0 in 2022, then soared by 113.14% to $77056.0 in 2023, then surged by 1125.08% to $944000.0 in 2024, then rose by 25.95% to $1.2 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $1.2 million (Q4 2025), $1.7 million (Q3 2025), and $1.9 million (Q2 2025) per Business Quant data.